Entry |
|
Name |
Bupranolol (INN) |
Formula |
C14H22ClNO2
|
Exact mass |
271.1339
|
Mol weight |
271.78
|
Structure |

|
Simcomp |
|
Class |
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
|
Remark |
|
Efficacy |
Antiglaucoma, beta-Adrenergic receptor antagonist |
Comment |
Propranolol derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
hsa04261 | Adrenergic signaling in cardiomyocytes |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AA Beta blocking agents, non-selective
C07AA19 Bupranolol
D07590 Bupranolol (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG00311 Bupranolol
D07590 Bupranolol
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB
D07590 Bupranolol (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01464 beta-Adrenergic receptor antagonist (Beta blocker)
DG00311 Bupranolol
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 18
1 O2a O 18.5500 -15.6800
2 C1b C 19.7400 -14.9800
3 C1c C 21.0000 -15.6800
4 C1b C 22.1900 -14.9800
5 O1a O 21.0000 -17.0800
6 N1b N 23.3800 -15.6800
7 C1d C 24.6400 -14.9800
8 C1a C 25.8300 -15.7500
9 C1a C 24.6400 -13.5800
10 C1a C 25.9000 -14.3500
11 C8y C 18.5500 -17.0800
12 C8y C 17.3600 -17.7800
13 C8x C 17.3600 -19.1800
14 C8x C 18.5500 -19.8800
15 C8y C 19.7400 -19.2500
16 C8x C 19.7400 -17.7800
17 X Cl 16.1700 -17.0800
18 C1a C 21.0000 -19.9500
BOND 18
1 1 2 1
2 2 3 1
3 3 4 1
4 3 5 1
5 4 6 1
6 6 7 1
7 7 8 1
8 7 9 1
9 7 10 1
10 1 11 1
11 11 12 2
12 12 13 1
13 13 14 2
14 14 15 1
15 15 16 2
16 11 16 1
17 12 17 1
18 15 18 1
|